Table 1.
Baseline characteristics and behavior of intravitreal Ozurdex implant in post-lensectomy–vitrectomy aphakic eyes
| Case | Age | Sex | Diagnosis | Eye | Pre-implant BCVA | Pre-implant IOP (mmHg) | Indication for Ozurdex implant | Treatment | Interval between implantation and migration into AC |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 47 | M | Chronic anterior uveitis | Right | 6/24 | 15 | Cystoid macular edema | Oral CS + azathioprine | 1 week |
| 2 | 13 | M | Behcets disease | Right | Counting fingers | 14 | Persistent intraocular inflammation | Oral CS + azathioprine/infliximab/cyclosporine | 8 days |
| 3 | 15 | M | Chronic anterior uveitis | Right | 6/36 | 6 | Ocular hypotony | Topical anti-inflammatory/cycloplegic therapy | 5 weeks |
M male, BCVA best corrected visual acuity, IOP intraocular pressure, CS corticosteroids, AC anterior chamber